Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review.
Publication
, Journal Article
Dato, PE; De La Cerda, J; Armstrong, AJ; Azad, AA; Conduit, C; Haas, GP; Kernen, K; Klaassen, ZW; Patel, R; Saad, F; Shore, ND; Freedland, SJ ...
Published in: Future Oncol
June 29, 2025
GOAL: To present data from published clinical trials of treatment of patients with prostate cancer with enzalutamide described in plain language and in a dashboard format available at: https://clinical-trials.dimensions.ai/enzalutamide-clinical-review/. RATIONALE: Treatments that are clinically active in advanced prostate cancer may benefit patients as they are treated earlier in the disease. OBJECTIVE: To show how overall survival improves as patients are treated with enzalutamide earlier in the disease.
Duke Scholars
Published In
Future Oncol
DOI
EISSN
1744-8301
Publication Date
June 29, 2025
Start / End Page
1 / 12
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Dato, P. E., De La Cerda, J., Armstrong, A. J., Azad, A. A., Conduit, C., Haas, G. P., … Karsh, L. I. (2025). Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review. Future Oncol, 1–12. https://doi.org/10.1080/14796694.2025.2475730
Dato, Paul E., Jose De La Cerda, Andrew J. Armstrong, Arun A. Azad, Ciara Conduit, Gabriel P. Haas, Kenneth Kernen, et al. “Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review.” Future Oncol, June 29, 2025, 1–12. https://doi.org/10.1080/14796694.2025.2475730.
Dato PE, De La Cerda J, Armstrong AJ, Azad AA, Conduit C, Haas GP, et al. Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review. Future Oncol. 2025 Jun 29;1–12.
Dato, Paul E., et al. “Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review.” Future Oncol, June 2025, pp. 1–12. Pubmed, doi:10.1080/14796694.2025.2475730.
Dato PE, De La Cerda J, Armstrong AJ, Azad AA, Conduit C, Haas GP, Kernen K, Klaassen ZW, Patel R, Saad F, Shore ND, Freedland SJ, Karsh LI. Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review. Future Oncol. 2025 Jun 29;1–12.
Published In
Future Oncol
DOI
EISSN
1744-8301
Publication Date
June 29, 2025
Start / End Page
1 / 12
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis